Artemis II Heads Home — And Science Keeps Rewriting the Rules
Editorial digest April 09, 2026
Last updated : 09:20
Four astronauts are hurtling toward Earth at thousands of kilometres per hour, carrying photographs no human eye has seen before and stories that will take months to fully tell. Artemis II — NASA's first crewed lunar mission in over half a century — is entering its final act. But while the world watches the skies, laboratories on the ground are quietly delivering discoveries that may matter just as much.
The Moon, again — and why it still matters
The Artemis II crew broke Apollo 13's distance record this week, travelling farther from Earth than any human in history. They swung past the Moon, snapped the first crewed lunar photographs since 1972, and are now on course for a splashdown expected on Saturday.
The mission has not been flawless. Technical malfunctions punctuated the journey — though NASA has remained tight-lipped on specifics — and the crew described moments of "overwhelming" emotion as they watched Earth shrink to a pale dot behind them. Commander Reid Wiseman told the BBC the team was returning with "all the good stuff," a phrase that belies the sheer volume of scientific data collected during the flyby.
For Britain, the mission carries particular resonance. Susan Charlesworth, who trains astronauts at the European Astronaut Centre, told the BBC that Artemis II would "inspire a whole generation." Meanwhile, scientists at the Mullard Space Science Laboratory in Dorking are preparing a separate mission to image Earth's magnetosphere — the invisible magnetic bubble that shields life from solar radiation. The two efforts are linked by a shared ambition: understanding the hostile environment beyond our atmosphere well enough to survive in it.
Artemis II is a test flight. No one landed on the Moon. But it proves the Orion capsule can carry humans to lunar orbit and bring them back — the essential prerequisite for Artemis III, which aims to put boots on the surface. After decades of false starts and funding battles, the road back to the Moon is, for the first time, genuinely open.
Your DNA decides how well Ozempic works
Closer to home, a study published this week offers a compelling answer to a question millions of patients have been asking: why do weight-loss jabs work brilliantly for some people and barely at all for others?
Researchers analysed data from nearly 28,000 patients taking GLP-1 medications — the drug class that includes semaglutide, sold as Ozempic and Wegovy. They found that variations in two specific genes involved in gut hormone pathways significantly affected both the amount of weight patients lost and the severity of side effects they experienced.
This is not a peripheral finding. GLP-1 drugs are the fastest-growing pharmaceutical category in the world, prescribed to millions and generating tens of billions in revenue. Yet the clinical reality is messy: some patients lose 20 per cent of their body weight, others lose almost nothing, and a significant minority abandon treatment because of nausea or other adverse effects. If genetic screening can predict who will respond well — and who won't — it could transform how these drugs are prescribed, saving the NHS both money and patient suffering.
The research is early-stage. No clinic is offering a "will Ozempic work for me?" DNA test yet. But the direction of travel is clear, and British healthcare, already stretched thin, has every reason to pay attention.
When physics gets strange
Two smaller stories this week deserve a mention — not because they'll change policy, but because they remind us how much remains genuinely unknown.
Researchers captured high-speed footage of oobleck droplets — the cornstarch-and-water mixture beloved of school science lessons — behaving as both liquid and solid simultaneously. The finding, published in Nature, is more than a curiosity. Understanding how non-Newtonian fluids transition between states has practical applications in manufacturing, body armour design, and even planetary science, where similar materials may exist on other worlds.
And then there is "Ghost Murmur." The CIA reportedly claimed to have used a quantum sensing device capable of detecting a human heartbeat from vast distances — allegedly deployed in Iran. Physicists pushed back hard. The public description, they say, clashes with the fundamental limits of magnetic sensing as currently understood. Either the CIA has made a breakthrough it isn't sharing, or the story is strategic theatre. Neither possibility is boring.
What it all adds up to
This has been a week where science operated on every scale at once — from the loneliness of deep space to the double helix inside a single cell. Artemis II reminded us that exploration is still dangerous, still expensive, and still worth doing. The genetics of weight loss showed that even blockbuster medicine has blind spots only basic research can illuminate. And a bowl of cornstarch proved, once again, that nature is under no obligation to behave the way we expect.
The astronauts splash down on Saturday. The real work — analysing what they brought back — begins the moment they're out of the water.
